Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)
Clinical trial NCT02134015 · TERMINATED
Trial details
- NCT number
- NCT02134015
- Sponsor
- Daiichi Sankyo
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-11-11
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.